Apellis Pharmaceuticals
Business Services · Massachusetts, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
100 5th Ave, Waltham, Massachusetts, 024...Phone Number
(617) 977-5700Website
www.apellis.comRevenue
$1.1 BillionIndustry
About Apellis Pharmaceuticals
Apellis Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for debilitating diseases driven by the complement system. The company applies complement science to advance medicines across areas including geographic atrophy and rare diseases, with a focus on improving outcomes for patients.Explore more
Apellis Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Apellis Pharmaceuticals
Compare insights from companies similar to Apellis Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Apellis Pharmaceuticals
$1.1B
501-1,000
Private
$721.1M
2008
DA
David AchesonExecutive Vice President, Head of Global Commercial
$418.2M
201-500
Public
$807.5M
2008
GB
Glenn BrameExecutive Vice President & Technical Chief & At Esperion Therapeutics Operations Officer
Apellis Pharmaceuticals Tech Stack
A closer look at the technologies used by Apellis Pharmaceuticals
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Apellis Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Apellis Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for debilitating diseases driven by the complement system. The company applies complement science to advance medicines across areas including geographic atrophy and rare diseases, with a focus on improving outcomes for patients.... Read More
